Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
ZyVersa Therapeutics Inc.
ZVSACurrent price
2.27 USD
-0.27 USD (-10.63%)
Last closed
2.47 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 341 756 USD
Yield for 12 month
-95.09 %
1Y
3Y
5Y
10Y
15Y
ZVSA
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. The company develops drug development platforms, including Cholesterol Efflux Mediator VAR 200, an injectable drug, which is in Phase 2a clinical trial to the treatment of renal indications, such as focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney diseases; and Inflammasome ASC Inhibitor IC 100, a humanized monoclonal antibody that is in preclinical stage for treatment of inflammatory diseases comprising acute respiratory syndrome, multiple sclerosis, IgA neuropathy, pancreatic cancer, Parkinson's and Huntington's disease, atherosclerosis, Alzheimer's disease, and obesity. ZyVersa Therapeutics, Inc. was founded in 2014 and is headquartered in Weston, Florida. Address: 2200 N. Commerce Parkway, Weston, FL, United States, 33326
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
70 USDP/E ratio
0.0019Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+15 600 USD
Current Year
-10 400 USD
Last Year
-10 400 USD
Current Quarter
-2 600 USD
Last Quarter
-10 439 USD
Key Figures ZVSA
1 year
3 years
5 years
10 years
EBITDA
-10 249 107 USD
Operating Margin TTM
PE Ratio
0.0019
Return On Assets TTM
-24.92 %
PEG Ratio
–
Return On Equity TTM
-152.23 %
Wall Street Target Price
70 USD
Revenue TTM
–
Book Value
10.33 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
1 163.36 USD
Diluted Eps TTM
1 163.36 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ZVSA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ZVSA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
26.04.2024
Dividend Date
–
Stock Valuation ZVSA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
0.0019
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-2.207
Price Book MRQ
0.2717
Financials ZVSA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ZVSA
For 52 weeks
2.08 USD
62.3 USD
50 Day MA
3.38 USD
Shares Short Prior Month
40 866
200 Day MA
6.42 USD
Short Ratio
0.55
Shares Short
49 566
Short Percent
4.62 %
BeatStart